| Liver injury after SARS‐CoV‐2 vaccination: Features of immune‐mediated hepatitis, role of corticosteroid therapy and outcome C Efe, AV Kulkarni, B Terziroli Beretta‐Piccoli, B Magro, ... Hepatology, 2022 | 79 | 2022 |
| Autoimmune hepatitis developing after the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine D Clayton-Chubb, D Schneider, E Freeman, W Kemp, SK Roberts Journal of hepatology, S0168-8278 (21) 00427-X, 0 | 60 | |
| Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives D Clayton-Chubb, W Kemp, A Majeed, JS Lubel, A Hodge, SK Roberts Nutrients 15 (3), 687, 2023 | 16 | 2023 |
| Thunderstorm asthma: revealing a hidden at‐risk population D Clayton‐Chubb, D Con, K Rangamuwa, D Taylor, F Thien, V Wadhwa Internal medicine journal 49 (1), 74-78, 2019 | 15 | 2019 |
| Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population‐based study W Kemp, D Clayton‐Chubb, A Majeed, KM Glenister, DJ Magliano, ... Journal of gastroenterology and hepatology 37 (2), 395-403, 2022 | 14 | 2022 |
| Results from a double blinded, randomised, placebo‐controlled, feasibility trial of melatonin for the treatment of delirium in older medical inpatients PW Lange, DI Clayton‐Chubb, R Watson, AB Maier Internal Medicine Journal 51 (1), 33-41, 2021 | 10 | 2021 |
| Acute medical stabilisation of adults with anorexia nervosa: experience of a defined interdisciplinary model of care MR Braude, D Con, D Clayton‐Chubb, R Nandurkar, LE Chua, ... Internal medicine journal 50 (1), 77-85, 2020 | 10 | 2020 |
| Moderate dose melatonin for the abatement and treatment of delirium in elderly general medical inpatients: study protocol of a placebo controlled, randomised, double blind trial DI Clayton-Chubb, PW Lange BMC geriatrics 16, 1-6, 2016 | 10 | 2016 |
| Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes K Vaz, D Clayton-Chubb, A Majeed, J Lubel, D Simmons, W Kemp, ... Hepatology International 17 (5), 1082-1097, 2023 | 9 | 2023 |
| Metabolic dysfunction‐associated steatotic liver disease in older adults is associated with frailty and social disadvantage D Clayton‐Chubb, WW Kemp, A Majeed, JS Lubel, RL Woods, C Tran, ... Liver International 44 (1), 39-51, 2024 | 6 | 2024 |
| Randomised clinical trial: adjunctive induction therapy with oral effervescent budesonide in newly diagnosed coeliac disease ED Newnham, D Clayton‐Chubb, M Nagarethinam, P Hosking, ... Alimentary Pharmacology & Therapeutics 54 (4), 419-428, 2021 | 6 | 2021 |
| Dynamics of liver stiffness in chronic hepatitis B patients with concurrent metabolic-associated fatty liver disease D Con, D Clayton-Chubb, J Lubel, R Sawhney, S Bloom Journal of Hepatology 75 (1), 236-238, 2021 | 4 | 2021 |
| Initial outcomes of a dedicated multidisciplinary non‐alcoholic fatty liver disease clinic: a retrospective cohort study I Commins, D Clayton‐Chubb, S Melton, A Majeed, W Kemp, SK Roberts Internal Medicine Journal 53 (11), 2065-2072, 2023 | 1 | 2023 |
| Testosterone and the risk of incident atrial fibrillation in older men: further analysis of the ASPREE study C Tran, BB Yeap, J Ball, D Clayton-Chubb, SM Hussain, A Brodtmann, ... EClinicalMedicine 72, 2024 | | 2024 |
| Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B D Con, S Tu, D Clayton-Chubb, JS Lubel, AJ Nicoll, R Sawhney, S Bloom Digestive Diseases and Sciences, 1-11, 2024 | | 2024 |
| Late-Life Metabolic Dysfunction-Associated Steatotic Liver Disease And Its Association With Physical Disability And Dementia D Clayton-Chubb, WW Kemp, A Majeed, RL Woods, J Ryan, AM Murray, ... The Journals of Gerontology, Series A: Biological Sciences and Medical …, 2024 | | 2024 |
| Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo‐controlled trial PW Lange, A Turbić, CH Soh, D Clayton‐Chubb, WK Lim, R Conyers, ... Journal of the American Geriatrics Society, 2024 | | 2024 |
| Diabetes and non‐alcoholic fatty liver disease: a bittersweet symphony D Clayton‐Chubb, SK Roberts The Medical Journal of Australia 219 (8), 353-354, 2023 | | 2023 |
| Management of hepatitis D in general practice. C Cosentino, D Clayton‑Chubb, JS Lubel Australian Journal of General Practice 52 (8), 2023 | | 2023 |
| Isolated IgG4-associated autoimmune hepatitis or the first manifestation of IgG4-related disease? C Cosentino, D Clayton-Chubb, C McLean, SK Roberts, W Kemp Hepatobiliary and Pancreatic Diseases International 22 (4), 415-417, 2023 | | 2023 |
Stuart K RobertsAlfred HealthVerified email at monash.edu
